Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study

Published 2014 View Full Article

Authors

Keywords

Journal

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Volume 71, Issue 3, Pages 484-492

Publisher

Elsevier BV

Online

2014-04-02

DOI

10.1016/j.jaad.2014.01.897

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer